Cargando…

Deciphering the Role of Melatonin-Related Signatures in Tumor Immunity and the Prognosis of Clear Cell Renal Cell Carcinoma

METHODS: Adopting multiomics data from TCGA and other public datasets, we analysed the expression, mutation, and prognostic evaluation in multiple cancers. ccRCC patients were categorized into two subgroups by an unsupervised cluster algorithm: melatonin-pattern cancer subtype 1 (MPCS1) and subtype...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Aimin, Cai, Chen, Yang, Yiren, Cui, Yankang, Liu, Wenqiang, Pang, Qingyang, Wu, Zhenjie, Liu, Bing, Qu, Le, Luo, Peng, Wang, Anbang, Wang, Linhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943605/ https://www.ncbi.nlm.nih.gov/pubmed/36825082 http://dx.doi.org/10.1155/2023/3077091

Ejemplares similares

A new thinking: deciphering the aberrance and clinical implication of copper-death signatures in clear cell renal cell carcinoma
por: Jiang, Aimin, et al.
Publicado: (2022)

Establishment of a prognosis Prediction Model Based on Pyroptosis-Related Signatures Associated With the Immune Microenvironment and Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma
por: Jiang, Aimin, et al.
Publicado: (2021)

A New Thinking: Deciphering the Aberrance and Clinical Implication of IGF Axis Regulation Pattern in Clear Cell Renal Cell Carcinoma
por: Jiang, Aimin, et al.
Publicado: (2022)

Establishment of a Prognostic Prediction and Drug Selection Model for Patients with Clear Cell Renal Cell Carcinoma by Multiomics Data Analysis
por: Jiang, Aimin, et al.
Publicado: (2022)

Integrative analysis of transcriptomic landscape and urinary signature reveals prognostic biomarkers for clear cell renal cell carcinoma
por: Zhang, Wei, et al.
Publicado: (2023)

DDX39 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with clear cell renal cell carcinoma
por: Bao, Yewei, et al.
Publicado: (2021)

Integrative transcriptome and proteome analyses of clear cell renal cell carcinoma develop a prognostic classifier associated with thrombus
por: Shi, Xiaolei, et al.
Publicado: (2023)

Excavation of diagnostic biomarkers and construction of prognostic model for clear cell renal cell carcinoma based on urine proteomics
por: Yang, Yiren, et al.
Publicado: (2023)

Prognosis Signature of Cuprotosis-Related lncRNAs Associated with Kidney Renal Clear Cell Carcinoma
por: Gao, Yiren, et al.
Publicado: (2022)

Deciphering a Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Clear Cell Renal Carcinoma
por: Bao, Jia-hao, et al.
Publicado: (2022)

Comprehensive analysis of the prognosis and immune infiltration of TMC family members in renal clear cell carcinoma
por: Tang, Wenbin, et al.
Publicado: (2023)

A novel thinking: DDR axis refines the classification of ccRCC with distinctive prognosis, multi omics landscape and management strategy
por: Jiang, Aimin, et al.
Publicado: (2022)

Long noncoding RNA EGFR-AS1 promotes cell growth and metastasis via affecting HuR mediated mRNA stability of EGFR in renal cancer
por: Wang, Anbang, et al.
Publicado: (2019)

Identification of autophagy-related long non-coding RNA prognostic and immune signature for clear cell renal cell carcinoma
por: Cui, Yankang, et al.
Publicado: (2021)

Comprehensive assessment gene signatures for clear cell renal cell carcinoma prognosis
por: Chang, Peng, et al.
Publicado: (2018)

Identification of a 5-Gene Signature Predicting Progression and Prognosis of Clear Cell Renal Cell Carcinoma
por: Pan, Qiufeng, et al.
Publicado: (2019)

Elevated SNRPA1, as a Promising Predictor Reflecting Severe Clinical Outcome via Effecting Tumor Immunity for ccRCC, Is Related to Cell Invasion, Metastasis, and Sunitinib Sensitivity
por: Jiang, Aimin, et al.
Publicado: (2022)

Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma
por: Cui, Yankang, et al.
Publicado: (2020)

Deciphering a cell death-associated signature for predicting prognosis and response to immunotherapy in lung squamous cell carcinoma
por: Mao, Guangxian, et al.
Publicado: (2023)

A feed-forward loop between lncARSR and YAP activity promotes expansion of renal tumour-initiating cells
por: Qu, Le, et al.
Publicado: (2016)

A five-long non-coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma
por: Shi, Da, et al.
Publicado: (2017)

A morphology-based nephrometry score to predict pathological upstaging to T3 renal cell carcinoma
por: Zhang, Wei, et al.
Publicado: (2022)

Copper Death Inducer, FDX1, as a Prognostic Biomarker Reshaping Tumor Immunity in Clear Cell Renal Cell Carcinoma
por: Jiang, Aimin, et al.
Publicado: (2023)

CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer Types
por: Jiang, Aimin, et al.
Publicado: (2022)

Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma
por: Jiang, Silin, et al.
Publicado: (2023)

EGFR-AS1 Promotes Bladder Cancer Progression by Upregulating EGFR
por: Wang, Anbang, et al.
Publicado: (2020)

A novel gene signature related to oxidative stress predicts the prognosis in clear cell renal cell carcinoma
por: Ma, Sheng, et al.
Publicado: (2023)

Novel amino acid metabolism‐related gene signature to predict prognosis in clear cell renal cell carcinoma
por: Cheng, Xiaofeng, et al.
Publicado: (2022)

Deciphering the mutational signature of congenital limb malformations
por: Sun, Liying, et al.
Publicado: (2021)

Anoikis-related genes signature development for clear cell renal cell carcinoma prognosis and tumor microenvironment
por: Jiang, Yinglei, et al.
Publicado: (2023)

Identification and Verification of m(7)G Modification Patterns and Characterization of Tumor Microenvironment Infiltration via Multi-Omics Analysis in Clear Cell Renal Cell Carcinoma
por: Dong, Kai, et al.
Publicado: (2022)

Machine learning-based prognosis signature for survival prediction of patients with clear cell renal cell carcinoma
por: Chen, Siteng, et al.
Publicado: (2022)

Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma
por: Wang, Yi, et al.
Publicado: (2021)

Identification of a 4-microRNA Signature for Clear Cell Renal Cell Carcinoma Metastasis and Prognosis
por: Wu, Xiwei, et al.
Publicado: (2012)

Solute carrier-related signature for assessing prognosis and immunity in patients with clear-cell renal cell carcinoma
por: BAO, WEI, et al.
Publicado: (2023)

Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma
por: Wu, Junlong, et al.
Publicado: (2019)

A novel amino acid metabolism-related gene risk signature for predicting prognosis in clear cell renal cell carcinoma
por: Su, Jiaqi, et al.
Publicado: (2022)

A pyroptosis-associated signature plays a role in prognosis prediction in clear cell renal cell carcinoma
por: Li, Zhiyuan, et al.
Publicado: (2022)

Antioxidant Gene Signature Impacts the Immune Infiltration and Predicts the Prognosis of Kidney Renal Clear Cell Carcinoma
por: Ren, Xueting, et al.
Publicado: (2021)

Cancer stem/progenitor signatures refine the classification of clear cell renal cell carcinoma with stratified prognosis and decreased immunotherapy efficacy
por: Zhou, Peng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5k1tsl4ds0ra0skm1g2gur3j2l